Award rate inequities in biomedical research.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2022
Historique:
received: 27 01 2022
accepted: 13 06 2022
entrez: 1 7 2022
pubmed: 2 7 2022
medline: 8 7 2022
Statut: epublish

Résumé

The analysis of existing institutional research proposal databases can provide novel insights into science funding parity. The purpose of this study was to analyze the relationship between race/ethnicity and extramural research proposal and award rates across a medical school faculty and to determine whether there was evidence that researchers changed their submission strategies because of differential inequities across submission categories. The authors performed an analysis of 14,263 biomedical research proposals with proposed start dates between 2010-2022 from the University of Michigan Medical School, measuring the proposal submission and award rates for each racial/ethnic group across 4 possible submission categories (R01 & Equivalent programs, other federal, industry, and non-profit). Researchers from each self-identified racial/ethnic group (Asian, Black/African American, Hispanic/Latino) pursued a different proposal submission strategy than the majority group (White). The authors found that Black/African American researchers experienced negative award rate differentials across all submission categories, which resulted in the lowest R01 & Equivalent and Other Federal submission rates of any racial/ethnic group and the highest submission rate to non-profit sources. The authors did not find support for the hypothesis that researchers changed submission strategies in response to award rate inequalities across submission categories. Biomedical researchers from different racial/ethnic groups follow markedly different proposal submission strategies within the University of Michigan Medical School. There is also a clear relationship between race/ethnicity and rates of proposal award. Black/African American and Asian researchers appear disadvantaged across all submission categories relative to White researchers. This study can be easily replicated by other academic research institutions, revealing opportunities for positive intervention.

Identifiants

pubmed: 35776730
doi: 10.1371/journal.pone.0270612
pii: PONE-D-22-02609
pmc: PMC9249172
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0270612

Déclaration de conflit d'intérêts

RK is employed by SciTech Strategies, Inc., a commercial entity. AZ is employed by Proposal Analytics, a benefit corporation. This does not alter our adherence to PLOS ONE policies on sharing data and materials. There are no patents, products in development or marketed products associated with this research to declare.

Références

Sci Adv. 2019 Oct 09;5(10):eaaw7238
pubmed: 31633016
Elife. 2021 Apr 13;10:
pubmed: 33847562
PLoS One. 2018 Sep 12;13(9):e0199648
pubmed: 30208016
Science. 2011 Aug 19;333(6045):925-6
pubmed: 21852462
Acad Med. 2016 Aug;91(8):1098-107
pubmed: 27306969
PLoS One. 2021 Nov 18;16(11):e0257559
pubmed: 34793439
Science. 2011 Aug 19;333(6045):1015-9
pubmed: 21852498
Cell. 2021 Feb 4;184(3):561-565
pubmed: 33503447

Auteurs

Alessandra Zimmermann (A)

Proposal Analytics, Inc., Wayne, PA, United States of America.

Richard Klavans (R)

SciTech Strategies, Wayne, PA, United States of America.

Heather M Offhaus (HM)

Office of Research, University of Michigan Medical School, Ann Arbor, MI, United States of America.

Teri A Grieb (TA)

Office of Research, University of Michigan Medical School, Ann Arbor, MI, United States of America.

Caleb Smith (C)

Office of Research, University of Michigan Medical School, Ann Arbor, MI, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH